ctrl K

Prime Medicine Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

1.74

0.01 (0.58%)

At close: May 01, 2025, 3:59 PM

1.78

2.59%

Pre-market: May 02, 2025, 09:09 AM EDT

Prime Medicine Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	2.98M	n/a	n/a	n/a	5.21M	n/a
Cost of Revenue	6.13M	147.91M	n/a	n/a	n/a	2.76M
Gross Profit	-3.15M	-147.91M	n/a	n/a	n/a	-2.76M
Operating Income	-202.47M	-191.29M	-116.54M	-84.47M	-932K	-2.17M
Interest Income	3.52M	n/a	n/a	n/a	n/a	n/a
Pretax Income	-195.88M	-198.41M	-122.77M	-165.85M	-1.54M	-2.52M
Net Income	-195.88M	-198.13M	-121.82M	-165.37M	-3.41M	-2.53M
Selling & General & Admin	50.16M	38.73M	29.82M	13.92M	3.16M	1.25M
Research & Development	155.29M	147.91M	86.72M	70.55M	2.98M	920K
Other Expenses	n/a	n/a	1.9M	-80.99M	-11.48M	n/a
Operating Expenses	205.45M	186.64M	116.54M	84.47M	6.14M	2.17M
Interest Expense	n/a	n/a	12.13M	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	-4.65M	n/a	n/a	n/a	1.25M
Cost & Expenses	205.45M	191.29M	116.54M	84.47M	6.14M	2.17M
Income Tax Expense	n/a	-279K	-948K	-486K	1.87M	4K
Shares Outstanding (Basic)	118.6M	90.97M	97.21M	64.9M	71.8M	95.73M
Shares Outstanding (Diluted)	118.6M	90.97M	97.21M	64.9M	71.8M	95.73M
EPS (Basic)	-1.65	-2.18	-1.25	-2.55	-0.07	-0.03
EPS (Diluted)	-1.65	-2.18	-1.25	-2.55	-0.07	-0.03
EBITDA	-196.34M	-193.76M	-110.75M	-160.99M	-889K	-2.17M
EBIT	-202.47M	-198.41M	-122.77M	-165.85M	-932K	-2.52M
Depreciation & Amortization	6.13M	4.65M	12.01M	4.86M	43K	6.52M